📊 Get daily AI-graded market briefings
Morning + evening · AI impact + sector exposure · Free
LAST 30 DAYS
2 articles
AVG GRADE
NEUTRAL
score: 0.00
SENTIMENT
NEUTRAL
TOTAL VIEWS
24
MDGL Latest News & AI Sentiment Analysis
2 articles · Grade: NEUTRAL · Real-time AI-graded coverage
RECENT COVERAGE · 7 ARTICLES
Madrigal Appoints John C. Reed, M.D., Ph.D., to its Board of Directors
Madrigal Pharmaceuticals announced a routine board appointment of John C. Reed, M.D., Ph.D., a recognized figure in pharmaceutical...
Madrigal Pharmaceuticals, Inc. (MDGL) Presents at Canaccord Genuity's 46th Annual Growth Conference Transcript
MDGL participated in Canaccord Genuity's 46th Annual Growth Conference on August 11, 2026, presenting company strategy and operational...
Madrigal Pharmaceuticals: Semaglutide Launch No Issue, Wise Pipeline Approach (NASDAQ:MDGL)
Madrigal Pharmaceuticals (MDGL) faces intensifying competitive pressure in the obesity-treatment space as semaglutide enters the market,...
Madrigal Pharmaceuticals, Inc. (MDGL) Q2 2026 Earnings Call Transcript
MDGL conducted its Q2 2026 earnings call on July 30, 2026, presenting quarterly operational and financial results to investors and...
BofA lowers its Price Target on Madrigal Pharmaceuticals, Inc. (MDGL)
Bank of America reduced its price target on Madrigal Pharmaceuticals (MDGL) by $8 per share, from $550 to $542, while maintaining a...
Ribo and Madrigal Reach First Major Milestone in Advancing Novel siRNA Therapies for MASH
Ribo and Madrigal Pharmaceuticals (MDGL) have jointly achieved a significant candidate drug nomination milestone in their siRNA...
Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)
Madrigal Pharmaceuticals announced routine equity inducement awards to five new non-executive employees under its 2025 Inducement Plan,...
E
ESEN Analytics
AI-powered equity research platform covering 5,000+ US equities. Our proprietary AI grading system (A+ to D scale) analyzes fundamentals, technicals, and news sentiment daily. Coverage data updated every 24 hours.
Learn about our methodology →
ⓘ AI-graded news coverage · Not investment advice